Cargando…
Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking
Imatinib (IMT) is the first-in-class BCR-ABL commercial tyrosine kinase inhibitor (TKI). However, the resistance and toxicity associated with the use of IMT highlight the importance of the search for new TKIs. In this context, heterocyclic systems, such as quinoline, which is present as a pharmacoph...
Autores principales: | Santos, Carine, Pimentel, Luiz, Canzian, Henayle, Oliveira, Andressa, Junior, Floriano, Dantas, Rafael, Hoelz, Lucas, Marinho, Debora, Cunha, Anna, Bastos, Monica, Boechat, Nubia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950477/ https://www.ncbi.nlm.nih.gov/pubmed/35337107 http://dx.doi.org/10.3390/ph15030309 |
Ejemplares similares
-
(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia
por: Pimentel, Luiz Claudio Ferreira, et al.
Publicado: (2021) -
New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells
por: Oliveira, Andressa, et al.
Publicado: (2022) -
Pyrroles as Privileged Scaffolds in the Search for New Potential HIV Inhibitors
por: Bianco, Maria da Conceição Avelino Dias, et al.
Publicado: (2021) -
The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines
por: C. S. Pinheiro, Luiz, et al.
Publicado: (2019) -
Toluene Dioxygenase-Catalyzed cis-Dihydroxylation of Quinolines: A Molecular Docking Study and Chemoenzymatic Synthesis of Quinoline Arene Oxides
por: Boyd, Derek R., et al.
Publicado: (2021)